Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms (original) (raw)

• Heymsfield, S. B. et al. in Handbook of Obesity: Etiology and Pathophysiology (eds. Bray, G. & Bouchard, C.) 33–79 (Marcel Dekker, New York, 2004).
  Google Scholar
• Flegal, K. M., Carroll, M. D., Ogden, C. L. & Johnson, C. L. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288 1723–1727 (2002).
  PubMed Google Scholar
• Mokdad, A. H. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76–79 (2003).
  PubMed Google Scholar
• Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N. Engl. J. Med. 348, 1625–1638 (2003). A landmark epidemiological study indicating that overweight and obesity are associated with mortality from a wide range of cancer types, and might explain 14% and 20% of all deaths from cancer in men and women from the United States, respectively.
  PubMed Google Scholar
• International Agency for Reasearch on Cancer. IARC Handbooks of Cancer Prevention. Weight Control and Physical Activity (International Agency for Research on Cancer, Lyon, 2002). An extensive report, prepared by an international expert panel, reviewing and summarizing epidemiological and experimental evidence relating increased cancer risk of excess weight. The report also includes a detailed discussion of hormonal and other mechanisms that might provide the physiological link between excess weight and tumour development.
• Willett, W. C. in Nutritional Epidemiology (ed. Willett, W.) 244–273 (Oxford University Press, New York, 1998).
  Google Scholar
• Kuczmarski, R. J. & Flegal, K. M. Criteria for definition of overweight in transition: background and recommendations for the United States. Am. J. Clin. Nutr. 72, 1074–1081 (2000).
  CAS PubMed Google Scholar
• James, P. T., Leach, R., Kalamara, E. & Shayeghi, M. The worldwide obesity epidemic. Obes. Res. 9 (Suppl. 4), 228–233 (2001).
  Google Scholar
• Seidell, J. C. in Progress in Obesity Research (eds. Medeiros-Neto, G., Halpern, A. & Bouchard, C.) 571–578 (John Libbey and Company, London, 2003).
  Google Scholar
• Seidell, J. & Rissanen, A. in Handbook of Obesity: Etiology and Pathophysiology (eds. Bray, G. & Bouchard, C.) 93–107 (Marcel Dekker, New York, 2004).
  Google Scholar
• Bjorntorp, P. Obesity. Lancet 350, 423–426 (1997).
  CAS PubMed Google Scholar
• Giovannucci, E., Colditz, G. A., Stampfer, M. J. & Willett, W. C. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7, 253–263 (1996).
  CAS PubMed Google Scholar
• Giovannucci, E. et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann. Intern. Med. 122, 327–334 (1995).
  CAS PubMed Google Scholar
• Calle, E. E., Miracle-McMahill, H. L., Thun, M. J. & Heath, C. W. Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J. Natl Cancer Inst. 87, 517–523 (1995).
  CAS PubMed Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002).
• Tchernof, A. & Despres, J. P. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm. Metab. Res. 32, 526–536 (2000).
  CAS PubMed Google Scholar
• Stephenson, G. D. & Rose, D. P. Breast cancer and obesity: an update. Nutr. Cancer 45, 1–16 (2003). An excellent and comprehensive review of the impact of adiposity on both breast cancer risk and the clinical behaviour of the established disease.
  CAS PubMed Google Scholar
• Potischman, N., Swanson, C. A., Siiteri, P. & Hoover, R. N. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J. Natl Cancer Inst. 88, 756–758 (1996).
  CAS PubMed Google Scholar
• Ballard-Barbash, R. & Swanson, C. A. Body weight: estimation of risk for breast and endometrial cancer. Am. J. Clin. Nutr. 63 (Suppl. 3), 437–441 (1996).
  Google Scholar
• Galanis, D. J. et al. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 9, 217–224 (1998).
  CAS PubMed Google Scholar
• Trentham-Dietz, A. et al. Body size and risk of breast cancer. Am. J. Epidemiol. 145, 1011–1119 (1997).
  CAS PubMed Google Scholar
• Hunter, D. J. & Willett, W. C. Diet, body size and breast cancer. Epidemiol. Rev. 15, 110–132 (1993).
  CAS PubMed Google Scholar
• Harvie, M., Hooper, L. & Howell, A. H. Central obesity and breast cancer risk: a systematic review. Obesity Rev. 4, 157–173 (2003).
  CAS Google Scholar
• Folsom, A. R. et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am. J. Epidemiol. 131, 794–803 (1990).
  CAS PubMed Google Scholar
• Huang, Z. et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 278, 1407–1411 (1997).
  CAS PubMed Google Scholar
• Barnes-Josiah, D., Potter, J. D., Sellers, T. A. & Himes, J. H. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States). Cancer Causes Control 6, 112–118 (1995).
  CAS PubMed Google Scholar
• Feigelson, H. S., Jonas, C. R., Teras, L. R., Thun, M. J. & Calle, E. E. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol. Biomark. Prev. 13, 220–224 (2004).
  Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 350, 1047–1059 (1997).
• Schairer, C. et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283, 485–491 (2000).
  CAS PubMed Google Scholar
• Rock, C. L. & Demark-Wahnefried, W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J. Clin. Oncol. 20, 3302–3316 (2002).
  PubMed Google Scholar
• Chlebowski, R. T., Aiello, E. & McTiernan, A. Weight loss in breast cancer patient management. J. Clin. Oncol. 20, 1128–1143 (2002).
  PubMed Google Scholar
• Petrelli, J. M., Calle, E. E., Rodriguez, C. & Thun, M. J. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of U. S. women. Cancer Causes Control 13, 325–332 (2002).
  PubMed Google Scholar
• Wee, C., McCarthy, E., Davis, R. & Phillips, R. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann. Intern. Med. 132, 697–704 (2000).
  CAS PubMed Google Scholar
• Reeves, M., Newcomb, P. A., Remington, P., Marcus, P. M. & MacKenzie, W. Body mass and breast cancer, relationship between method of detection and stage of disease. Cancer 77, 301–307 (1996).
  CAS PubMed Google Scholar
• Kaaks, R., Lukanova, A. & Kurzer, M. A. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol. Biomark. Prev. 11, 1531–1543 (2002).
  CAS Google Scholar
• Lew, E. A. & Garfinkel, L. Variations in mortality by weight among 750,000 men and women. J. Chron. Dis. 32, 563–576 (1979).
  CAS PubMed Google Scholar
• Bergstrom, A. et al. Obesity and renal cell cancer — a quantitative review. Br. J. Cancer 85, 984–990 (2001).
  CAS PubMed PubMed Central Google Scholar
• Hu, J., Mao, Y., White, K. & The Canadian Cancer Registries Epidemiology Research Group. Overweight and obesity in adults and risk of renal cell carcinoma in Canada. Soz Praventivmed. 48, 178–185 (2003).
  PubMed Google Scholar
• Pan, S. Y. et al. Association of obesity and cancer risk in Canada. Am. J. Epidemiol. 159, 259–268 (2004).
  PubMed Google Scholar
• Samanic, C. et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15, 35–43 (2004).
  PubMed Google Scholar
• World Cancer Research Fund & American Institute for Cancer Research. in Food, Nutrition and the Prevention of Cancer: a global perspective 371–373 (Am. Instit. Cancer Res., Washington, 1997).
• Hill, H. A. & Austin, H. Nutrition and endometrial cancer. Cancer Causes Control 7, 19–32 (1996).
  CAS PubMed Google Scholar
• Wolk, A., Lindblad, P. & Adami, H. -O. Nutrition and renal cell cancer. Cancer Causes Control 7, 5–18 (1996).
  CAS PubMed Google Scholar
• Chow, W. H. et al. Obesity and risk of renal cell cancer. Cancer Epidemiol. Biomarkers Prev. 5, 17–21 (1996).
  CAS PubMed Google Scholar
• Mellemgaard, A., Engholm, G., McLaughlin, J. K. & Olsen, J. H. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int. J. Cancer 56, 66–71 (1994).
  CAS PubMed Google Scholar
• McLaughlin, J. et al. A population-based case-control study of renal cell carcinoma. J. Natl Cancer Inst. 72, 275–284 (1984).
  CAS PubMed Google Scholar
• McLaughlin, J. K. et al. Risk factors for renal-cell cancer in Shanghai, China. Int. J. Cancer 52, 562–565 (1992).
  CAS PubMed Google Scholar
• Chow, W. H., Gridley, G., Fraumeni, J. F. & Jarvholm, B. Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 343, 1305–1311 (2000).
  CAS PubMed Google Scholar
• Devesa, S. S., Blot, W. J. & Fraumeni, J. F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83, 2049–2053 (1998).
  CAS PubMed Google Scholar
• Wild, C. P. & Hardie, L. J. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nature Rev. Cancer 3, 676–685 (2003).
  CAS Google Scholar
• Wu, A. H. & Bernstein, L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control 12, 721–732 (2001).
  CAS PubMed Google Scholar
• Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825–831 (1999).
  CAS PubMed Google Scholar
• Chow, W. H. et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274, 474–477 (1995).
  CAS PubMed Google Scholar
• Nilsson, M., Johnsen, R., Weimin, Y., Hveem, K. & Lagergren, J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290, 66–72 (2003).
  CAS PubMed Google Scholar
• Lagergren, J., Bergstrom, R. & Nyren, O. No relation between body mass and gastro-esophageal reflux symptoms in a Swedish population based study. Gut 47, 26–29 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chow, W. H. et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl Cancer Inst. 90, 150–55 (1998).
  CAS PubMed Google Scholar
• Lagergren, J., Bergstrom, R., Adami, H. O. & Nyren, O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann. Intern. Med. 133, 165–175 (2000).
  CAS PubMed Google Scholar
• Moller, H., Mellemgaard, A., Lindvig, K. & Olsen, J. H. Obesity and cancer risk: a Danish record-linkage study. Eur. J. Cancer 30A, 344–350 (1994).
  CAS PubMed Google Scholar
• Gapstur, S. M. et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283, 2552–2558 (2000).
  CAS PubMed Google Scholar
• Michaud, D. S. et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286, 921–929 (2001).
  CAS PubMed Google Scholar
• Silverman, D. T. et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J. Natl Cancer Inst. 90, 1710–1719 (1998).
  CAS PubMed Google Scholar
• Hanley, A. J. G., Johnson, K. C., Villeneuve, P. J. & Mao, Y. Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int. J. Cancer 94, 140–147 (2001).
  CAS PubMed Google Scholar
• Berrington de Gonzalez, A., Sweetland, S. & Spencer, E. A meta-analysis of obesity and the risk of pancreatic cancer. Br. J. Cancer 89, 519–523 (2003).
  CAS PubMed Google Scholar
• Lee, I. -M., Sesso, H. D., Oguma, Y. & Paffenbarger, R. S. Physical activity, body weight, and pancreatic cancer mortality. Br. J. Cancer 88, 679–683 (2003).
  PubMed PubMed Central Google Scholar
• Zatonski, W. et al. Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int. J. Cancer 48, 390–394 (1991).
  CAS PubMed Google Scholar
• Howe, G. R., Jain, M. & Miller, A. B. Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study. Int. J. Cancer 45, 604–608 (1990).
  CAS PubMed Google Scholar
• Ghadirian, P., Simard, A., Baillargeon, J., Maisonneuve, P. & Boyle, P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int. J. Cancer 47, 1–6 (1991).
  CAS PubMed Google Scholar
• Bueno de Mesquita, H. B., Moerman, C. J., Runia, S. & Maisonneuve, P. Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas? Int. J. Cancer 46, 435–444 (1990).
  CAS PubMed Google Scholar
• Wolk, A. et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12, 13–21 (2001).
  CAS PubMed Google Scholar
• Strom, B. L. et al. Risk factors for gallbladder cancer. Cancer 76, 1747–1756 (1995).
  CAS PubMed Google Scholar
• Zatonski, W. A. et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J. Natl Cancer Inst. 89, 1132–1138 (1997).
  CAS PubMed Google Scholar
• Ji, B. -T. et al. Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China. Cancer Epidemiol. Biomarkers Prev. 6, 481–485 (1997).
  CAS PubMed Google Scholar
• Vaughan, T. L., Davis, S., Kristal, A. & Thomas, D. B. Obesity, alcohol, and tobacco as risk factors fo cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 4, 85–92 (1995).
  CAS PubMed Google Scholar
• Henley, S. J., Flanders, W. D., Manatunga, A. & Thun, M. J. Leanness and lung cancer risk: fact or artifact? Epidemiology 13, 268–276 (2002).
  PubMed Google Scholar
• Tornberg, S. A. & Carstensen, J. M. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br. J. Cancer 69, 358–361 (1994).
  CAS PubMed PubMed Central Google Scholar
• Lacey, J. V. et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98, 814–821 (2003).
  PubMed Google Scholar
• Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl Cancer Inst. 90, 1774–1786 (1998).
  CAS PubMed Google Scholar
• Rodriguez, C., Calle, E. E., Fakhrabadi-Shokoohi, D., Jacobs, E. J. & Thun, M. J. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol. Biomark. Prev. 11, 822–828 (2002).
  Google Scholar
• Engeland, A., Tretli, S. & Bjorge, T. Height, body mass index, and ovarian cancer: a follow-up of 1. 1 million Norwegian women. J. Natl Cancer Inst. 95, 1244–1248 (2003).
  PubMed Google Scholar
• Fairfield, K. M. et al. Obesity, weight gain, and ovarian cancer. Obstet. Gynecol. 100, 288–296 (2002).
  PubMed Google Scholar
• Kuper, H., Cramer, D. W. & Titus-Ernstoff, L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13, 455–463 (2002).
  PubMed Google Scholar
• Lubin, F. et al. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am. J. Epidemiol. 157, 113–120 (2003).
  CAS PubMed Google Scholar
• Schouten, L. J., Goldbohm, A. & van den Brandt, P. A. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am. J. Epidemiol. 157, 424–433 (2003).
  PubMed Google Scholar
• Calle, E. E. Invited commentary: Do anthropometric measures predict risk of prostate cancer? Am. J. Epidemiol. 151, 550–553 (2000).
  CAS PubMed Google Scholar
• Engeland, A., Tretli, S. & Bjorge, T. Height, body mass index, and prostate cancer: a follow-up of 950,000 Norwegian men. Br. J. Cancer 89, 1237–1242 (2003).
  CAS PubMed PubMed Central Google Scholar
• Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A. & Willett, W. C. Height, body weight, and risk of prostate cancer. Cancer Epidemiol. Biomark. Prev. 6, 557–563 (1997).
  CAS Google Scholar
• Andersson, S. O. et al. Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J. Natl Cancer Inst. 89, 385–389 (1997).
  CAS PubMed Google Scholar
• Rodriguez, C. et al. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol. Biomark. Prev. 10, 345–353 (2001).
  CAS Google Scholar
• Amling, C. L. et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J. Clin. Oncol. 22, 439–445 (2004).
  PubMed Google Scholar
• Freedland, S. J. et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital Database Study Group. J. Clin. Oncol. 22, 446–453 (2004).
  PubMed Google Scholar
• Holly, E. A., Lele, C., Bracci, P. M. & McGrath, M. S. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay area, California. Am. J. Epidemiol. 150, 375–389 (1999).
  CAS PubMed Google Scholar
• Cerhan, J. R. et al. Anthropometric characteristics, physical activity and risk of non-Hodgkin's lymphoma subtypes and B-cell lymphocytic leukemia: a prospective study. Am. J. Epidemiol. 156, 527–535 (2003).
  Google Scholar
• Rajala, M. W. & Scherer, P. E. Minireview: the adipocyte — at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765–3773 (2003).
  CAS PubMed Google Scholar
• Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988).
  CAS PubMed Google Scholar
• Wajchenberg, B. L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697–738 (2000).
  CAS PubMed Google Scholar
• McKeown-Eyssen, G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomarkers Prev. 3, 687–695 (1994).
  CAS PubMed Google Scholar
• Giovannucci, E. Insulin and colon cancer. Cancer Causes Control 6, 164–179 (1995).
  CAS PubMed Google Scholar
• Kaaks, R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7, 605–625 (1996).
  CAS PubMed Google Scholar
• Stoll, B. A. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur. J. Clin. Nutr. 53, 83–87 (1999).
  CAS PubMed Google Scholar
• Weiderpass, E. et al. Occurrence, trends and environment etiology of pancreatic cancer. Scand. J. Work Environ. Health 24, 165–174 (1998).
  CAS PubMed Google Scholar
• Lawlor, M. A. & Alessi, D. R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J. Cell Sci. 114, 2903–2910 (2001).
  CAS PubMed Google Scholar
• Prisco, M., Romano, G., Peruzzi, F., Valentinis, B. & Baserga, R. Insulin and IGF-I receptors signaling in protection from apoptosis. Horm. Metab. Res. 31, 80–89 (1999).
  CAS PubMed Google Scholar
• Ish-Shalom, D. et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40 (Suppl. 2), 25–31 (1997).
  Google Scholar
• Le Roith, D. Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor. Growth Horm. IGF Res. 10 (Suppl. A), 12–13 (2000).
  Google Scholar
• Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A. & Friend, K. E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 21, 215–244 (2000).
  CAS PubMed Google Scholar
• Shafie, S. M. & Grantham, F. H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl Cancer Inst. 67, 51–56 (1981).
  CAS PubMed Google Scholar
• Shafie, S. M. & Hilf, R. Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats. Cancer Res. 41, 826–829 (1981).
  CAS PubMed Google Scholar
• Heuson, J. C. & Legros, N. Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo. Eur. J. Cancer 6, 349–351 (1970).
  CAS PubMed Google Scholar
• Heuson, J. C. & Legros, N. Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res. 32, 226–232 (1972).
  CAS PubMed Google Scholar
• Cocca, C. et al. An experimental model of diabetes and cancer in rats. Eur. J. Cancer 34, 889–894 (1998).
  CAS PubMed Google Scholar
• Cocca, C. et al. Suppression of mammary gland tumorigenesis in diabetic rats. Cancer Detect. Prev. 27, 37–46 (2003).
  PubMed Google Scholar
• LeRoith, D. & Roberts, C. T. Jr. The insulin-like growth factor system and cancer. Cancer Lett. 195, 127–137 (2003).
  CAS PubMed Google Scholar
• Wideroff, L. et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl Cancer Inst. 89, 1360–1365 (1997).
  CAS PubMed Google Scholar
• Lindblad, P. et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42, 107–112 (1999).
  CAS PubMed Google Scholar
• Everhart, J. & Wright, D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273, 1605–1609 (1995).
  CAS PubMed Google Scholar
• Kaaks, R. et al. Serum C-peptide, insulin-like growth factor (IGF)-I, Igf-binding proteins, and colorectal cancer risk in women. J. Natl Cancer Inst. 92, 1592–1600 (2000). Provides the first concrete evidence, from a prospective cohort study, that increased circulating insulin levels are a risk factor for the development of colon cancer.
  CAS PubMed Google Scholar
• Stattin, P. et al. Obesity and colon cancer: does leptin provide a link? Int. J. Cancer 109, 149–152 (2004).
  CAS PubMed Google Scholar
• Schoen, R. E. et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J. Natl Cancer Inst. 91, 1147–1154 (1999).
  CAS PubMed Google Scholar
• Lukanova, A. et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1-2 and-3 and risk of endometrial cancer. Int. J. Cancer 108, 262–268 (2004). Gives the first solid evidence, from a prospective cohort study, that increased circulating insulin levels are a risk factor for the development of endometrial cancer.
  CAS PubMed Google Scholar
• Bruning, P. F. et al. Insulin resistance and breast cancer risk. Int. J. Cancer 52, 511–516 (1992).
  CAS PubMed Google Scholar
• Del Giudice, M. E. et al. Insulin and related factors in premenopausal breast cancer. Breast Cancer Res. Treat. 47, 111–120 (1998).
  CAS PubMed Google Scholar
• Hirose, K. et al. Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac. J. Cancer Prev. 4, 239–246 (2003).
  PubMed Google Scholar
• Yang, G. et al. Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 10, 1207–1211 (2001).
  CAS PubMed Google Scholar
• Schairer, C. et al. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int. J. Cancer 108, 773–779 (2004).
  CAS PubMed Google Scholar
• Kaaks, R. et al. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13, 307–316 (2002).
  PubMed Google Scholar
• Keinan-Boker, L. et al. Circulating levels of insulin-like growth factor I, its binding proteins-1,-2,-3, C-peptide and risk of postmenopausal breast cancer. Int. J. Cancer 106, 90–95 (2003).
  CAS PubMed Google Scholar
• Muti, P. et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol. Biomarkers Prev. 11, 1361–1368 (2002).
  CAS PubMed Google Scholar
• Toniolo, P. et al. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer 88, 828–832 (2000).
  CAS PubMed Google Scholar
• Clemmons, D. R. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell Endocrinol. 140, 19–24 (1998).
  CAS PubMed Google Scholar
• Kaaks, R. & Lukanova, A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc. Nutr. Soc. 60, 91–106 (2001).
  CAS PubMed Google Scholar
• Thissen, J. P., Ketelslegers, J. M. & Underwood, L. E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15, 80–101 (1994).
  CAS PubMed Google Scholar
• Allen, N. E. et al. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14, 65–74 (2003).
  PubMed Google Scholar
• Holmes, M. D., Pollak, M. N. & Hankinson, S. E. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol. Biomarkers Prev. 11, 862–867 (2002).
  CAS PubMed Google Scholar
• Lukanova, A. et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int. J. Cancer 101, 549–554 (2002).
  CAS PubMed Google Scholar
• Chapman, I. M. et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J. Clin. Endocrinol. Metab. 83, 2836–2842 (1998).
  CAS PubMed Google Scholar
• Tannenbaum, G. S., Guyda, H. J. & Posner, B. I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220, 77–79 (1983).
  CAS PubMed Google Scholar
• Hankinson, S. E. et al. Circulating concertrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351, 1393–1396 (1998).
  CAS PubMed Google Scholar
• Stattin, P. et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J. Natl Cancer Inst. 92, 1910–1917 (2000).
  CAS PubMed Google Scholar
• Chan, J. M. et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563–566 (1998).
  CAS PubMed Google Scholar
• Giovannucci, E. et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev. 9, 345–349 (2000).
  CAS Google Scholar
• Ma, J. et al. A prospective study of plasma levels of insulin-like growth factor I, insulin-like growth factor binding protein 3 and colorectal cancer risk among men. J. Natl Cancer Inst. 91, 620–625 (1999).
  CAS PubMed Google Scholar
• Palmqvist, R. et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50, 642–646 (2002).
  CAS PubMed PubMed Central Google Scholar
• Key, T. J., Allen, N. E., Verkasalo, P. K. & Banks, E. Energy balance and cancer: the role of sex hormones. Proc. Nutr. Soc. 60, 81–89 (2001).
  CAS PubMed Google Scholar
• Key, T. J. et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl Cancer Inst. 95, 1218–1226 (2003). This paper presents a re-analysis of the original data from nine prospective cohort studies on the relationships between excess weight, alterations in circulating sex-hormone levels and breast cancer risk.
  CAS PubMed Google Scholar
• Pugeat, M. et al. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J. Steroid Biochem. Mol. Biol. 40, 841–849 (1991).
  CAS PubMed Google Scholar
• Kokkoris, P. & Pi-Sunyer, F. X. Obesity and endocrine disease. Endocrinol. Metab. Clin. North Am. 32, 895–914 (2003).
  CAS PubMed Google Scholar
• Kaaks, R., Lukanova, A. & Sommersberg, B. Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis. 3, 157–172 (2000).
  CAS PubMed Google Scholar
• Strain, G. W. et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism 31, 871–875 (1982).
  CAS PubMed Google Scholar
• Amatruda, J. M., Harman, S. M., Pourmotabbed, G. & Lockwood, D. H. Depressed plasma testosterone and fractional binding of testosterone in obese males. J. Clin. Endocrinol. Metab. 47, 268–271 (1978).
  CAS PubMed Google Scholar
• Poretsky, L., Cataldo, N. A., Rosenwaks, Z. & Giudice, L. C. The insulin-related ovarian regulatory system in health and disease. Endocr. Rev. 20, 535–582 (1999).
  CAS PubMed Google Scholar
• Ehrmann, D. A., Barnes, R. B. & Rosenfield, R. L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 16, 322–353 (1995).
  CAS PubMed Google Scholar
• Dunaif, A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997).
  CAS PubMed Google Scholar
• Robinson, S. et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol. 39, 351–355 (1993).
  CAS Google Scholar
• Dickson, R. B. & Stancel, G. M. Estrogen receptor-mediated processes in normal and cancer cells. J. Natl Cancer Inst. Monogr. 27, 135–145 (2000).
  CAS Google Scholar
• Flototto, T. et al. Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm. Metab. Res. 33, 451–457 (2001).
  CAS PubMed Google Scholar
• Key, T. J. & Pike, M. C. The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer. Br. J. Cancer 57, 205–212 (1988).
  CAS PubMed PubMed Central Google Scholar
• Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst. 94, 606–616 (2002).
• Zeleniuch-Jacquotte, A. et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br. J. Cancer 90, 153–159 (2004).
  CAS PubMed PubMed Central Google Scholar
• Coates, R. J. et al. Race, nutritional status, and survival from breast cancer. J. Natl Cancer Inst. 82, 1684–1692 (1990).
  CAS PubMed Google Scholar
• Tretli, S., Haldorsen, T. & Ottestad, L. The effect of pre-morbid height and weight on the survival of breast cancer patients. Br. J. Cancer 62, 299–303 (1990).
  CAS PubMed PubMed Central Google Scholar
• Maehle, B. O. & Tretli, S. Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res. Treat. 41, 123–130 (1996).
  CAS PubMed Google Scholar
• Lukanova, A. et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int. J. Cancer 108, 425–432 (2004).
  CAS PubMed Google Scholar
• Zeleniuch-Jacquotte, A. et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br. J. Cancer 84, 975–981 (2001).
  CAS PubMed PubMed Central Google Scholar
• Hsing, A. W., Reichardt, J. K. & Stanczyk, F. Z. Hormones and prostate cancer: current perspectives and future directions. Prostate 52, 213–235 (2002).
  CAS PubMed Google Scholar
• Bosland, M. C. The role of steroid hormones in prostate carcinogenesis. J. Natl Cancer Inst. Monogr. 27, 39–66 (2000).
  CAS Google Scholar
• Harrison, S. A. & Diehl, A. M. Fat and the liver: a molecular overview. Semin. Gastroint. Dis. 13, 3–16 (2002).
  Google Scholar
• Festi, D. et al. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 5, 27–42 (2004).
  CAS PubMed Google Scholar
• Hill, J. O., Wyatt, H. R., Reed, G. W. & Peters, J. C. Obesity and the environment: where do we go from here? Science 299, 853–855 (2003).
  CAS PubMed Google Scholar
• Allison, D. B., Fontaine, K. R., Manson, J. E., Stevens, J. & VanItallie, T. B. Annual deaths attributable to obesity in the United States. JAMA 282, 1530–1538 (1999).
  CAS PubMed Google Scholar
• Banegas, J. R., Lopez-Garcia, E., Gutierriz-Fisac, J. L., Guallar-Castillon, P. & Rodriguez-Artalejo, F. A simple estimate of mortality attributable to excess weight in the European Union. Eur. J. Clin. Nutr. 57, 201–208 (2003).
  CAS PubMed Google Scholar
• Finkelstein, E. A., Fiebelkorn, I. C. & Wang, G. State-level estimates of annual medical expenditures attributable to obesity. Obes. Res. 12, 18–24 (2004).
  PubMed Google Scholar
• Sturm, R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Affairs 21, 245–253 (2002).
  PubMed Google Scholar
• Mokdad, A., Marks, J., Stroup, D. & Gerberding, J. Actual causes of death in the United States, 2000. JAMA 291, 1238–1245 (2004).
  PubMed Google Scholar
• McTigue, K. M. et al. Screening and interventions for obesity in adults: summary of the evidence for the U. S. Preventive Services Task Force. Ann. Intern. Med. 139, 933–949 (2003). Current clinical guidelines to promote effective screening and intervention for obesity in adult populations, based on systematic reviews of all trials and observation studies of the health outcomes of obesity and efficacy of obesity treatment.
  PubMed Google Scholar
• Chopra, M., Galbraith, S. & Darnton-Hill, I. A global response to a global problem: the epidemic of overnutrition. Bull. World Health Organ. 80, 952–958 (2002).
  PubMed Google Scholar
• Byers, T. et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 52, 92–119 (2002).
  PubMed Google Scholar
• Royal College of Physicians, Royal College of Paediatrics and Child Health, and Faculty of Public Health Medicine. Storing up problems: the medical case for a slimmer nation [online], <www.rcplondon.ac.uk/pubs/brochures/pub_print_SUP.htm> (2004).
• Mercer, J. G., O'Reilly, J. M. & Morgan, P. J. Increasing the impact of European obesity research in preparation for the European research area: a report on the 2003 European Commission obesity workshop. Obes. Rev. 5, 79–86 (2004).
  CAS PubMed Google Scholar
• World Health Organization. Global strategy on diet, physical activity and health [online], <www.who.int/dietphysicalactivity/strategy/eb11344/en/> (2004).
• Borkan, G., Hultz, D., Gerzof, S., Robbins, A. H. & Silbert, C. K. Age changes in body composition revealed by computed tomography. J. Gerontol. 38, 673–677 (1983).
  CAS PubMed Google Scholar
• US Department of Agriculture and US Department of Health and Human Services. Nutrition and your health: dietary guidelines for Americans (US Government Printing Office, Washington, DC, 2000).
• WHO Expert Committee. Physical Status: the Use and Interpretation of Anthropometry. WHO Technical Report Series 854 (World Health Organization, Geneva, 1995).
• National Institutes of Health and National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults — the evidence report. Obes. Res. 6 (Suppl. 2), 51–209 (1998).
• Rockhill, B., Newman, B. & Weinberg, C. Use and misuse of population attributable fractions. Am. J. Public Health 88, 15–19 (1998).
  CAS PubMed PubMed Central Google Scholar
• Bergman, R. N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351–356 (2000).
  CAS PubMed Google Scholar
• Ebeling, P. & Koivisto, V. A. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man. Diabetologia 37, 202–209 (1994).
  CAS PubMed Google Scholar
• Randle, P. J. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14, 263–283 (1998).
  CAS PubMed Google Scholar
• Havel, P. J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13, 51–59 (2002).
  CAS PubMed Google Scholar
• Hotamisligil, G. S. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl. 4), 23–27 (2000).
  Google Scholar
• Kahn, B. B. & Flier, J. S. Obesity and insulin resistance. J. Clin. Invest. 106, 473–481 (2000). An excellent review of the physiological mechanisms leading to insulin resistance.
  CAS PubMed PubMed Central Google Scholar
• Steppan, C. M. & Lazar, M. A. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13, 18–23 (2002).
  CAS PubMed Google Scholar
• Trayhurn, P. & Beattie, J. H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60, 329–339 (2001).
  CAS PubMed Google Scholar
• Ukropec, J., Sebokova, E. & Klimes, I. Nutrient sensing, leptin and insulin action. Arch. Physiol. Biochem. 109, 38–51 (2001).
  CAS PubMed Google Scholar
• Le Roith, D. & Zick, Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24, 588–597 (2001).
  CAS PubMed Google Scholar
• Moller, D. E. & Flier, J. S. Insulin resistance — mechanisms, syndromes, and implications. N. Engl. J. Med. 325, 938–948 (1991).
  CAS PubMed Google Scholar
• Virkamaki, A., Ueki, K. & Kahn, C. R. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103, 931–943 (1999).
  CAS PubMed PubMed Central Google Scholar
• Henriksen, E. J. Invited review: Effects of acute exercise and exercise training on insulin resistance. J. Appl. Physiol. 93, 788–796 (2002).
  CAS PubMed Google Scholar
• Borghouts, L. B. & Keizer, H. A. Exercise and insulin sensitivity: a review. Int. J. Sports Med. 21, 1–12 (2000).
  CAS PubMed Google Scholar
• Pedersen, O. Genetics of insulin resistance. Exp. Clin. Endocrinol. Diabetes 107, 113–118 (1999).
  CAS PubMed Google Scholar
• Grundy, S. M., Abate, N. & Chandalia, M. Diet composition and the metabolic syndrome: what is the optimal fat intake? Am. J. Med. 113 (Suppl. 9B), 25–29 (2002).
  Google Scholar
• Kopp, W. High-insulinogenic nutrition — an etiologic factor for obesity and the metabolic syndrome? Metabolism 52, 840–844 (2003).
  CAS PubMed Google Scholar
• Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14, 15–19 (2003).
  CAS PubMed Google Scholar
• Grundy, S. M., Brewer, H. B. Jr., Cleeman, J. I., Smith, S. C. Jr. & Lenfant, C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433–438 (2004).
  PubMed Google Scholar
• Reaven, G. M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75, 473–486 (1995).
  CAS PubMed Google Scholar
• National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 1999–2000 [online], <www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.htm.> (2004)
• Bergstrom, A., Pisani, P., Tenet, V., Wolk, A. & Adami, H. O. Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer 91, 421–430 (2001).
  CAS PubMed Google Scholar